Company News-News

2025-01-21

Great Bay Bio Partners with Prof Chen from MIT to Co-develop Novel Tumor Antibody

Recently, Great Bay Bio (GBB) partnered with Professor JZ Chen from the Koch Institute for Integrative Cancer Research

2025-01-06

Comparison Results of AlfaMedx vs. 17 Commercial Media Released

Great Bay Bio self-developed AI-enabled cell culture media, AlfaMedX (NF3370+DF2025), leverages cutting-edge technologies, including AI, to analyze and predict large volumes of experimental data. This approach optimizes the composition and usage condition

2024-12-30

Great Bay Bio Recognized as One of the Top 50 Innovative Biotechnology Companies in Guangdong-Hong Kong-Macao Greater Bay Area Award 2024

The Guangdong-Hong Kong-Macao Greater Bay Area Biotech Innovation Summit and the 7th Top 50 Innovative Biotech Compani

2024-12-16

Great Bay Bio Completes First Close of Series B Financing

Hong Kong December 16, 2024 Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B

2024-11-08

Launched Intelligent Cell Culture Media, AlfaMedX

The AlfaMedX platform applies AI technology to the development of cell culture media formulations, establishing a media formulation algorithm platform to develop media suitable for cell growth, protein expression, and cell differentiation, including basal

2024-11-07

Great Bay Bio and MEGAROBO Forge Strategic Partnership

Hong Kong November 7, 2024 D

2024-10-18

Great Bay Bio Intelligent Drug Development Ecosystem Officially Launched

Hong Kong

2024-08-27

Great Bay Bio Listed on Forbes Asia 100 to Watch 2024

Great Bay Bio was successfully selected for Forbes Asia 100 to Watch 2024 List.